Neil Herskowitz, Director at MANHATTAN PHARMACEUTICALS INC (MHA), bought 10,000 shares at $0.68 ($7K) on 2006-07-13, disclosed to the SEC on 2006-07-31.
Open-market purchase of $7k MHA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.73 | 500 | $365 | 5.4% |
| 2 | $0.71 | 4,500 | $3K | 47.1% |
| 3 | $0.68 | 2,500 | $2K | 25.1% |
| 4 | $0.61 | 2,500 | $2K | 22.5% |
| Total | $0.68 avg | 10,000 | $7K | 100% |
| Filing → |
| ATXI | BUY | 2021-05-07 | $10K | — | Filing → |
| ATXI | BUY | 2020-03-02 | $21K | — | Filing → |
| ATXI | BUY | 2020-02-25 | $93K | — | Filing → |